InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,300.80
(
0.45%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.42
(
1.12%
)
Bitcoin
61,545.80
(
1.21%
)

Replies to post #63327 on Ariad Pharmaceuticals Inc fka ARIA

Replies to #63327 on Ariad Pharmaceuticals Inc fka ARIA

investor maven

05/16/15 9:14 AM

#63329 RE: Sikmarson #63327

The data showed that nilotinib caused as many CV events as ponatinib... why wasn't it pulled of the market by FDA for relabeling?

Any suggestions?